| Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation: report of 10 cases A Skalova, T Vanecek, P Martinek, I Weinreb, TM Stevens, RHW Simpson, ... The American journal of surgical pathology 42 (2), 234-246, 2018 | 169 | 2018 |
| Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue SJ Potts, JS Krueger, ND Landis, DA Eberhard, GD Young, ... Laboratory investigation 92 (9), 1342-1357, 2012 | 146 | 2012 |
| Cytometry analysis system and method using database-driven network of cytometers S Potts, L Dietz, A Kantor, B Reynolds, I Walton US Patent App. 10/274,297, 2003 | 85 | 2003 |
| Molecular basis explanation for imatinib resistance of BCR‐ABL due to T315I and P‐loop mutations from molecular dynamics simulations TS Lee, SJ Potts, H Kantarjian, J Cortes, F Giles, M Albitar Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 64 | 2008 |
| Methods for feature analysis on consecutive tissue sections S Potts, T Johnson, F Voelker, GD Young US Patent 8,787,651, 2014 | 47 | 2014 |
| Proteomic‐based prediction of clinical behavior in adult acute lymphoblastic leukemia M Albitar, SJ Potts, FJ Giles, S O'Brien, M Keating, D Thomas, C Clarke, ... Cancer 106 (7), 1587-1594, 2006 | 42 | 2006 |
| Digital pathology in drug discovery and development: multisite integration SJ Potts Drug discovery today 14 (19-20), 935-941, 2009 | 33 | 2009 |
| Development of a novel, accurate, automated, rapid, high-throughput technique suitable for population-based carrier screening for Fragile X syndrome CM Strom, D Huang, Y Li, FM Hantash, J Rooke, SJ Potts, W Sun Genetics in Medicine 9 (4), 199-207, 2007 | 33 | 2007 |
| The role and impact of quantitative discovery pathology SJ Potts, GD Young, FA Voelker Drug discovery today 15 (21-22), 943-950, 2010 | 32 | 2010 |
| Molecular basis of antagonism between K70E and K65R tenofovir-associated mutations in HIV-1 reverse transcriptase RM Kagan, TS Lee, L Ross, RM Lloyd Jr, MA Lewinski, SJ Potts Antiviral research 75 (3), 210-218, 2007 | 31 | 2007 |
| Cell-based tissue analysis H Lange, J Krueger, GD Young, T Johnson, F Voelker, S Potts US Patent 9,488,639, 2016 | 25 | 2016 |
| Basis for resistance to imatinib in 16 BCR-ABL mutants as determined using molecular dynamics TS Lee, SJ Potts, M Albitar Recent patents on anti-cancer drug discovery 4 (2), 164-173, 2009 | 18 | 2009 |
| TRKA expression and NTRK1 gene copy number across solid tumours G Mauri, E Valtorta, G Cerea, A Amatu, M Schirru, G Marrapese, V Fiorillo, ... Journal of Clinical Pathology 71 (10), 926-931, 2018 | 15 | 2018 |
| P14.19 Preclinical and clinical efficacy of entrectinib in primary and metastatic brain tumors harboring NTRK, ROS1, or ALK gene fusions S Rangaraju, A Farago, KM Heym, M Ahn, A Drilon, S Potts, Z Hornby, ... Neuro-Oncology 19 (suppl_3), iii106-iii106, 2017 | 13 | 2017 |
| Nucleic acid size detection method D Huang, CM Strom, SJ Potts, JE Rooke US Patent 8,163,480, 2012 | 13 | 2012 |
| Proteomics-based prediction of clinical response in acute myeloid leukemia M Albitar, SJ Potts, FJ Giles, S O'Brien, I Jilani, AC Donahue, EH Estey, ... Experimental hematology 37 (7), 784-790, 2009 | 13 | 2009 |
| Detection and removal of chitinous material in a biological sample SJ Potts, DC Slaughter, JF Thompson, JJ Payne, BA Cohen US Patent 6,833,250, 2004 | 12 | 2004 |
| Challenges of target/compound data integration from disease to chemistry: a case study of dihydrofolate reductase inhibitors SJ Potts, DJ Edwards, R Hoffman Current Drug Discovery Technologies 2 (2), 75-87, 2005 | 10 | 2005 |
| Nucleic acid size detection method D Huang, CM Strom, SJ Potts, JE Rooke US Patent 8,697,399, 2014 | 9 | 2014 |
| Tissue pattern recognition error rates and tumor heterogeneity in gastric cancer SJ Potts, SE Huff, H Lange, V Zakharov, DA Eberhard, JS Krueger, ... Applied Immunohistochemistry & Molecular Morphology 21 (1), 21-30, 2013 | 9 | 2013 |
Taisung LeeRutgers UniversityVerified email at rutgers.edu
